Literature DB >> 20818925

Burden on UK secondary care of rotavirus disease and seasonal infections in children.

Christopher Morgan1, Nick Adlard, Stuart Carroll, Latha Parvataneni.   

Abstract

OBJECTIVE: Rotavirus is a common infection affecting children under 5 years, which leads to a significant disease burden. This burden is potentially exacerbated by the seasonality of rotavirus, particularly in the context of the seasonality of other common childhood infections. The primary study objective was to describe the pattern and burden of seasonal infections amongst children under 5 years of age with particular attention placed on rotavirus and other gastrointestinal infections.
METHODS: A retrospective analysis of all routine inpatient data relating to selected seasonal infections in the UK was conducted between 2001/02 and 2007/08 using data from Capse Healthcare Knowledge Systems (CHKS, England, Northern Ireland and Wales) and Information Services Division (ISD, Scotland). Admissions with selected diagnoses were extracted based on International Classification of Diseases (ICD)-10 coding. All episodes were processed using a HRG grouper and costs applied according to the NHS National Tariff.
RESULTS: In the financial year 2007/08, the total number of admissions in the UK for children under 5 years for the selected seasonal infections was 64,879 of which 32,126 admissions were associated with gastrointestinal infections including rotavirus gastroenteritis (RVGE). Seasonal peaks of gastrointestinal infections and RVGE occurred in the spring quarter and respiratory syncytial virus (RSV) and influenza in the winter quarter. Admissions for gastrointestinal infection including RVGE accounted for 35 003 bed days with 9922 due to RVGE. The total cost for admissions involving a diagnosis of seasonal infection was £56 million. Of this, it was estimated that infections with an ICD-10 classification of rotavirus represented a cost of £8.6 million.
CONCLUSION: Rotavirus contributes to the significant burden that seasonal infections place on inpatient paediatric resources during the winter and spring months. This study may be limited by issues of clinical coding and the infrequency of confirmatory microbiological testing in real-world practice. Vaccination might be considered as a means of reducing this clinical and economic burden particularly where long-term effectiveness and ease of administration are proven.

Entities:  

Mesh:

Year:  2010        PMID: 20818925     DOI: 10.1185/03007995.2010.518135

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  7 in total

1.  Orbital decompression for Graves' orbitopathy in England.

Authors:  P Perros; T Chandler; C M Dayan; A J Dickinson; P Foley; J Hickey; C J Macewen; J H Lazarus; J McLaren; G E Rose; J M Uddin; B Vaidya
Journal:  Eye (Lond)       Date:  2011-12-09       Impact factor: 3.775

Review 2.  Do current cost-effectiveness analyses reflect the full value of childhood vaccination in Europe? A rotavirus case study.

Authors:  Bernd Brüggenjürgen; Mathie Lorrot; Fiona R Sheppard; Vanessa Rémy
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 3.  Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: a scoping review.

Authors:  Isla Ogilvie; Hanane Khoury; Mireille M Goetghebeur; Antoine C El Khoury; Carlo Giaquinto
Journal:  BMC Infect Dis       Date:  2012-03-19       Impact factor: 3.090

4.  Stool submission data to help inform population-level incidence rates of enteric disease in a Canadian community.

Authors:  K Franklin; F Pollari; B J Marshall; K D M Pintar; A Nesbitt; I Young; S A McEwen; J Vanderlaan; A Papadopoulos
Journal:  Epidemiol Infect       Date:  2014-09-12       Impact factor: 4.434

5.  The cost of hospital care for management of invasive group A streptococcal infections in England.

Authors:  G J Hughes; A J VAN Hoek; S Sriskandan; T L Lamagni
Journal:  Epidemiol Infect       Date:  2014-09-29       Impact factor: 4.434

6.  Intussusception incidence among infants in the UK and Republic of Ireland: a pre-rotavirus vaccine prospective surveillance study.

Authors:  Lamiya Samad; Mario Cortina-Borja; Haitham El Bashir; Alastair G Sutcliffe; Sean Marven; J Claire Cameron; Richard Lynn; Brent Taylor
Journal:  Vaccine       Date:  2013-07-17       Impact factor: 3.641

7.  Economic Cost of Campylobacter, Norovirus and Rotavirus Disease in the United Kingdom.

Authors:  Clarence C Tam; Sarah J O'Brien
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.